Ataluren Terminated Phase 2 Trials for Hereditary factor IX deficiency / Hemophilia A Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00947193Study of Ataluren (PTC124®) in Hemophilia A and B